Information
Name of lifestyle Body mass index
Third Class Body mass index(BMI)
Second Class Biochemical examination
First Class Clinical characteristics
Unit kg/m²
%
Stratification 18444148:NA
24053657:NA
25908534:NA
21627376:<21.0;21.0-22.9 ;23.0-24.9;≥25.0;<23.0;25.0-26.9;≥27.0
18211697:< 25;25-30;>30
19436298:≤23.4;23.5-25.2;25.2-26.8;26.8-28.7;≥28.7
17623560:≤24;24-27;27-29;>29.0
10964002:<24.1;24.1-26.6;>26.6;>5.0%loss;With5.0%;5.1%-10.0%gain;10.1%-15.0%gain;>15.0%gain
11065004:<24;24-26;26.1-28;>28
18704722:Normal(<25kg/m²);Overweight/obese (≥25kg/m²)
15380796:≥0.86-≤2.44;>2.44-≤2.66;>2.66-≤2.87;>2.87-≤6.05
19277881:<18.5;18.5-24.9;25.0-29.9;≥30.0
19816779:<24;24-26;27-29;30+
20157773:<21.99 ;22.0-24.7 ;24.8-28.0 ;≥28.1
15010890:<25;>25;Continuous
15280622:<24.4;24.4-27.2;27.3-29.8;≥29.9
11142419:<19.8 ;19.8-21.4;21.5-23.5 ;23.6-36.1
11505174:<24.053;24.053-26.660;>26.660
26243447:<25;25-29.9;30-34.9;≥35
17301263:NA
17851770:18.5-24.9 ;25-29.9 ;≥30
24156935:NA
25884961:<25;≥25
27535659:<25;≥ 25
23656798:< 25;25–29.9;≥ 30
28332895:kg/m²
28910820:<25;≥25,<30;≥30,<35;≥35
Type of influence factor Protective factor
Risk factor
No statistical significance factor
Classification of Lifestyles Clinical characteristics
The affected types of PCa Total PCa
Gleason ≥7 PCa
Aggressive PCa
Non Aggressive PCa
Local PCa
Advanced PCa
Unstaged PCa
Low grade PCa
High grade PCa
Regional/remote PCa
High risk PCa
Number of studies involved 27
27 Items, 2 Pages <<Prev 1 2 Next>> All
Research involved
PMID First auther Year Area Duration Study type Sample size More
18444148 Gholamreza Pourmand 2008 Iran November 2005, December 2006 Case-Control 62;68 baseline
outcome
24053657 Sepehr Salem 2013 Iran NA case-control 194;317 baseline
outcome
25908534 Cosimo De Nunzio 2016 Italy January 2010 Questionnaires 180;106 baseline
outcome
21627376 Mitsuru Mori 2011 Japan January 2007, April 2008 468 outcome
18211697 Laura Q Rogers 2008 United States of America cross-sectional 2524;61138 baseline
outcome
19436298 P Wallstro¨m 2009 Sweden 74138 outcome
17623560 Gerarda Ann Darlington 2007 Canada (Ontario) 1995, 1998 case–control 1613;752 baseline
outcome
10964002 SHANNON D. PUTNAM 2000 United States of America (Iowa) 1986, 1989 1572 outcome
11065004 Josep M.Ramon 2000 Spain (Barcelona metropolitan area) May 1994, March 1998 case-control 217;434 baseline
outcome
18704722 Lindsay Mag 2008 United States of America (Fargo,ND) 2004, 2006 hospital-based case–control 312;319 outcome
15380796 NANCY LIGHTFOOT 2004 Canada (Ontario) 1995, 1999 case–control 760;1632 outcome
19277881 Richard M. Martin 2009 Norway 1995, 2005 questionnaires 22659;6595 baseline
outcome
19816779 Sheila Weinmann 2010 United States of America (Kaiser Permanente Northern California Region,Kaiser Permanente Southern California Region,Henry Ford Health System,or Kaiser Permanente Northwest Region) 1997, 2001 case–control 768;929 outcome
20157773 Maria D. Jackson 2010 Jamaica (Kingston Metropolitan area) March 2005, July 2007 case–control 243;105;130;275 baseline
outcome
15010890 YANCUI 2004 1988, 1994 case-control 95;8720 outcome
15280622 Maureen Sanderson 2004 United States of America (California) 2000, 2002 case–control 416;429 outcome
11142419 Ann W. Hsing, 2000 China (Shanghai) 1993, 1995 case-control 471;238;79;150 baseline
outcome
11505174 Colin R. Sharpe 2000 Canada (Montreal) 1979, 1985 399;476 baseline
outcome
26243447 Song-Yi Park 2015 United States of America (Hawaii and California) 1993, 1996 Cohort 75216 outcome
17301263 Pentti Tuohimaa 2007 Helsinki 1981, 1982 case-control 132;456 baseline
outcome